BRN.AX stock A$0.145 on 09 Feb 2026 Market closed: AI progress vs valuation

BRN.AX stock closed at A$0.145 on 09 Feb 2026, up +3.57% on higher-than-average volume. BrainChip Holdings Ltd (BRN.AX) trades on the ASX in Australia and works on neuromorphic AI chips for edge devices. The session was Market closed and volume hit 10,240,181 shares, signalling renewed investor attention to its AI roadmap and near-term catalysts.

BRN.AX stock: Price action and intraday drivers

BrainChip (BRN.AX) finished the day at A$0.145, with a day range of A$0.135–A$0.145. Trading volume was 10,240,181, above the 30‑day average of 8,959,143, which drove the stock higher by 3.57% on the close.

BRN.AX stock: Financials and valuation metrics

BrainChip reports EPS -A$0.02 and a negative P/E of -7.00, reflecting losses. Key valuation ratios show a price-to-sales of 176.22 and price-to-book of 13.41, while the company holds a strong current ratio of 5.18 and low debt-to-equity of 0.07. These numbers show healthy liquidity but rich valuation for a small revenue base.

BRN.AX stock: Technicals and trading signals

Momentum indicators show mixed signals: RSI 60.30 and MFI 86.99, suggesting short-term overbought conditions. The 50‑day average sits near A$0.172 and the 200‑day at A$0.197, so price remains below both moving averages, indicating a medium-term downtrend.

BRN.AX stock: Strategic outlook in the AI sector

BrainChip sells the Akida neuromorphic processor for ultra-low power edge AI, a relevant niche as demand for on-device AI rises. Sector peers in Technology show stronger revenue multiples, underscoring BrainChip’s early-stage commercialisation and the need for clearer revenue scaling.

BRN.AX stock: Meyka AI grade and model forecast

Meyka AI rates BRN.AX with a score of 64.88 out of 100 (Grade B, HOLD). This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst signals. Meyka AI’s forecast model projects monthly A$0.11, quarterly A$0.09, and yearly A$0.166, compared with the current A$0.145. The yearly projection implies +14.65% upside versus today’s price. Forecasts are model-based projections and not guarantees.

BRN.AX stock: Risks and opportunities

Opportunity: BrainChip’s neuromorphic IP could win design slots in automotive and security markets, unlocking higher revenue. Risk: high valuation against small revenue, negative margins, and a recent external rating of C- (Strong Sell) on 06 Feb 2026 indicate investor caution. Balance sheet liquidity is a mitigating factor.

Final Thoughts

Key takeaways for BRN.AX stock on 09 Feb 2026: BrainChip closed at A$0.145 on the ASX with strong volume of 10,240,181 shares, reflecting active investor interest in its neuromorphic AI strategy. Financials show negative earnings and rich valuation metrics, including price-to-sales 176.22 and price-to-book 13.41, but the company has a solid current ratio 5.18 and low leverage. Meyka AI’s forecast model projects a yearly A$0.166, implying about +14.65% upside from the close. Our proprietary grade is B (HOLD), balancing sector opportunity against execution and valuation risks. For active AI stock investors, monitor the 50‑day average A$0.172, upcoming earnings on 2026-03-04, and any commercial design wins. Forecasts are model-based projections and are not guarantees. Read more on Meyka BRN page and follow recent coverage on MarketBeat BRN news and comparative data at Investing.com. Meyka AI is an AI-powered market analysis platform.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.